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Abstract
Background: Streptococcus agalactiae (Group B Streptococcus) is a leading cause of sepsis and meningitis in newborns.
Most bacterial pathogens, including gram-positive bacteria, have long filamentous structures known as pili extending from
their surface. Although pili are described as adhesive organelles, they have been also implicated in many other functions
including thwarting the host immune responses. We previously characterized the pilus-encoding operon PI-2a (gbs1479-
1474) in strain NEM316. This pilus is composed of three structural subunit proteins: PilA (Gbs1478), PilB (Gbs1477), and PilC
(Gbs1474), and its assembly involves two class C sortases (SrtC3 and SrtC4). PilB, the bona fide pilin, is the major component
whereas PilA, the pilus associated adhesin, and PilC the pilus anchor are both accessory proteins incorporated into the pilus
backbone.
Methodology/Principal Findings: In this study, the role of the major pilin subunit PilB was tested in systemic virulence
using 6-weeks old and newborn mice. Notably, the non-piliated DpilB mutant was less virulent than its wild-type
counterpart in the newborn mice model. Next, we investigated the possible role(s) of PilB in resistance to innate immune
host defenses, i.e. resistance to macrophage killing and to antimicrobial peptides. Phagocytosis and survival of wild-type
NEM316 and its isogenic DpilB mutant in immortalized RAW 264.7 murine macrophages were not significantly different
whereas the isogenic DsodA mutant was more susceptible to killing. These results were confirmed using primary peritoneal
macrophages. We also tested the activities of five cationic antimicrobial peptides (AMP-1D, LL-37, colistin, polymyxin B, and
mCRAMP) and found no significant difference between WT and DpilB strains whereas the isogenic dltA mutant showed
increased sensitivity.
Conclusions/Significance: These results question the previously described role of PilB pilus in resistance to the host
immune defenses. Interestingly, PilB was found to be important for virulence in the neonatal context.
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Introduction
Streptococcus agalactiae (also referred to as Group B Streptococcus,
GBS) is a gram-positive encapsulated bacterium responsible for
life-threatening infections in newborns, elderly, and adults with
underlying diseases [1,2]. Two distinct clinical syndromes, early-
onset disease (EOD) or late-onset disease (LOD) have been
described in neonates and young infants [3]. For EOD, the main
route of infection is assumed to be a vertical transmission from
inhalation during parturition of S. agalactiae-contaminated vaginal
or amniotic fluid, resulting in subsequent systemic infection after
translocation across the respiratory epithelium. For LOD, the
mode of transmission and the infection route still remains unclear.
Once into the bloodstream, S. agalactiae can cause septicemia and
then cross the blood-brain barrier to cause meningitis.
Bacterial pili have recently been recognized in major human
pathogens such as S. agalactiae, Streptococcus pyogenes (GAS), and
Streptococcus pneumoniae (for reviews see [4,5,6,7,8,9]). Sortase-
mediated pilus assembly was first demonstrated in Corynebacterium
diphtheriae [10,11] and these pioneer studies revealed the existence
of three conserved motifs within the major pilin subunit that are
necessary for pilus formation: i) the pilin motif (WxxxVxVYPK); ii)
the E-box domain (YxLxETxAPxGY); and iii) the cell wall sorting
signal (LPxTG followed by a hydrophobic domain and a positively
charged tail). The current model for pilus assembly is as follows:
the major subunit is assembled to form a pilus by a cis-encoded
sortase that catalyzes the covalent attachment of the conserved
lysyl residue of the pilin motif of one subunit with the conserved
threonyl residue of the LPxTG motif of another subunit. In
addition, one or more accessory subunits are incorporated into the
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specific sortase. The crystallographic structures of two major pilins
have now shown that the E-box domain is involved in the
formation of intramolecular isopeptide bond conferring higher
stability to the pilin monomer [12,13]. Then, during the final step,
the pilus fiber is covalently linked to the peptidoglycan by either
the pilus-specific or the housekeeping sortase. This mechanism of
pilus assembly catalyzed by class C sortases has now been
characterized in several gram-positive pathogens using similar
genetic and biochemical analyses [14,15,16,17,18,19,20,21,22].
Three genomic loci (PI-1, PI-2a, and PI-2b) have been described
in GBS strains [23], the latter two being mutually exclusive as they
are located at the same chromosomal location. In a survey of 289
GBS clinical isolates, PI-1, PI-2a, and PI-2b were detected in 72%,
73%, and 27% of the strains, the combination of PI-1 + PI-2a being
the most frequent [24]. We and others previously carried out a
detailed structural and functional analysis of the pilus locus PI-2a
(gbs1479–1474) in GBS strain NEM316 [16,23]. This locus encodes
the three structural pilus subunits PilA (Gbs1478), PilB (Gbs1477),
and PilC (Gbs1474) whose assembly involves two class C sortases
(SrtC3 and SrtC4). PilB, the bona fide pilin, is the major component;
PilC is a minorassociated componentmainlylocalizedat the base of
the pilus [25]; and PilA is the adhesin located at intervals along the
pilus backbone [16]. The PI-2a GBS pili have also been implicated
in mediating attachment to human epithelial cells [16,26,27], in
biofilm formation [26,28], in the adhesion and invasion of brain
microvascular endothelial cells [29], and in promoting transepithe-
lial migration [30].
Intriguingly, the pilin subunit PilB of PI-2a was also reported to
mediate resistance to cathelicidin antimicrobial peptide and
phagocyte killing, to increase bloodstream survival, and to confer
virulence in a mouse challenge model [31].
Here, we re-investigate the contribution of PilB in the virulence
of strain NEM316 using two different mice models and in
resistance to innate host immune defenses by testing GBS survival
to killing by macrophages or antimicrobial peptides.
Results
PilB mutant is attenuated for virulence in a neonatal
mouse infection model
To investigate the role of the pilus in invasive disease, we made
use of the previously described in-frame deletion mutant of
gbs1477, encoding the backbone protein PilB in GBS strain
NEM316 [16] in combination with the heterologous expression of
PilB under the constitutive lactococcal p23 promoter in the non-
pathogenic host Lactococcus lactis strain NZ9000. As shown by
Western blotting using anti-PilB polyclonal antibody, expression of
pilB in L. lactis strain NZ9000 was associated with the presence in
the cell wall extracts of a band of 75 kDa corresponding to PilB
monomer that was missing in the control strain L. lactis harboring
the cloning vector without DNA insert (Fig. 1). As previously
shown [16], PilB appears mainly as a polymer in GBS strain
NEM316 (Fig. 1) whereas PilB monomers are directly anchored to
the cell wall in L. lactis.
S. agalactiae and lactococcal strains were then tested in parallel
for 6-weeks old CD1 mice were challenged intravenously with two
doses (10
7 or 5610
7 CFU) of GBS NEM316 and DpilB mutant,
and with a higher dose (5610
8 CFU) of L. lactis strains NZ9000
expressing or not pilB, and blood was collected 24 h later to
enumerate viable bacterial CFUs. As shown in Fig. 2A and 2B, no
significant differences were found between strains expressing or
not pilB in these conditions. It is worth noting that the inter-animal
variability is quite important in these experiments.
We then tested the role of PilB in a neonatal sepsis model.
BALB/c mice (#24 h-old) were infected subcutaneously with low
(17 to 30 CFU) and high (30 to 60 CFU) GBS challenge inoculum
(Fig. 2C and 2D, respectively). At low dose, only 60% of the mice
infected with 17 CFU of WT strain survived whereas 100% of
mice infected with 30 CFU of DpilB mutant survived (Fig 2C).
More strikingly, only 40% of the mice infected with 30 CFU of
WT strain survived whereas all the mice survived when infected
with 60 CFU of DpilB mutant (Fig. 2D). Thus in both experiments,
we consistently observed that a higher number of mice survived
when challenged with DpilB mutant as compared to WT strain
after 24 h post-infection demonstrating the importance of PilB
pilus of S. agalactiae NEM316 in the neonatal context.
PilB does not promote bacterial survival in murine
macrophages
The survival of GBS strain NEM316 and its isogenic non-
piliated mutant DpilB was compared in the widely used murine
macrophage cell line RAW 264.7. We also included as control the
NEM316DsodA mutant which was previously shown to display
increased susceptibility to bacterial killing by macrophages [32].
As shown in Fig. 3A, the wild-type strain NEM316 (WT) and the
DpilB mutant displayed a similar survival kinetic in this phagocytic
cell line. In contrast, survival of the isogenic DsodA mutant was
significantly reduced compared to the wild-type strain.
Since phagocytic cell lines are considered to be less harmful for
bacteria than primary macrophages, we performed similar
Figure 1. Surface expression of pilB in S. agalactiae and in
recombinant L. lactis strains. Immunoblots of cell-wall protein
extracts of GBS and recombinant L. lactis strains with the antiserum
against PilB. Numbers indicate the size of molecular weight marker in
kDa. The positions of the monomeric (m) and polymeric (p) form of PilB
are marked by arrowheads.
doi:10.1371/journal.pone.0018747.g001
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rophages. S. agalactiae and lactococcal strains were tested in parallel
for survival in murine peritoneal macrophages (Fig. 3B). Whereas
piliated S. agalactiae NEM316 WT and non-piliated DpilB mutant
survived similarly, a dramatic phagocytic killing of both lacto-
coccal strains was observed (20-fold decreased as compared to
GBS strains). No gain of function was noticed for the L. lactis strain
expressing pilB when compared to the L. lactis strain expressing the
vector alone.
Altogether these results indicate that NEM316 PilB is not
involved in resistance to bacterial killing by macrophages.
PilB does not confer resistance to antimicrobial peptides
It has been shown by others that GBS NCTC10/84DpilB
exhibited enhanced susceptibility to various cationic antimicrobial
peptides CAMPs (mCRAMP, polymyxin B, and LL-37). We thus
tested the activities of four cationic molecules having similar net
charges such as AMP-1D (+6), LL-37 (+6), colistin (+5) and
polymyxin B (+5) by determining the minimal inhibitory
concentration required to inhibit the growth of 90% of the
bacteria (MIC90). As shown in Table 1, no difference was found
between GBS WT and the isogenic DpilB mutant. In contrast, the
dltA mutant showed increased sensitivity to these CAMPs, as
shown previously [33]. For consistency with our animal models,
we also tested the effect of various concentrations of the murine
cathelicidin mCRAMP (+6) on the growth curve of WT, DpilB,
and DdltA in TH medium (Fig. 4). Again, no significant difference
was found between WT and the DpilB mutant. Similar results were
obtained using this experimental condition for the three other
tested CAMPs: colistine, AMP-1D, and polymyxin B (data not
shown). We also observed that expression of pilB in L. lactis
NZ9000 did not modify the MIC90 towards these antibiotics
(Table 1), nor the bacterial growth (Fig. S1). Collectively, our
results do not support a role for the pilus in resistance to cationic
antimicrobial peptides.
Discussion
The goal of the present work was to evaluate the contribution of
the pilin subunit PilB of the GBS pilus-encoding operon PI-2a to
bacterial virulence. This was done either by deleting the
corresponding gene pilB in the WT serotype III strain NEM316
or by expressing it in the food grade bacterium L. lactis NZ9000. In
a 6 weeks old CD1 septicemic mouse model, we observed that PilB
was dispensable for bacterial virulence in both genetic back-
grounds. These results conflict with those of Maisey et al. (2008)
who reported that PilB of GBS NCTC10/84, a highly hemolytic
serotype V strain [34], conferred virulence to the parental GBS
strain and to L. lactis, as assessed in a similar animal model.
Moreover, over-expression of the pilB gene alone in the non-
pathogenic L. lactis was found to enhance resistance to phagocyte
killing, increased bloodstream survival, and conferred virulence in
a mouse model [31]. The latter observation was intriguing as it
suggested that PilB is an essential GBS virulence factor, being
sufficient to turn the unencapsulated and non-pathogenic
bacterium L. lactis into an invasive extracellular bacteria.
The molecular basis of PilB-associated virulence is thought to
reside in its ability to confer resistance to CAMP and phagocytosis,
Figure 2. Role of PilB in virulence. A- Bacterial loads in blood of 6-weeks CD1 mice collected 24 h post-intravenous injection with GBS or
recombinant L. lactis strains (4 mice per strain). B- Similar experiment than in A with higher GBS inoculum (6 mice per strain). C- Survival index of
newborn mice infected intraperitoneally with lower inoculum (7 pups per strain). D- Same experiment as in C with higher inoculum (9 pups per
strain).
doi:10.1371/journal.pone.0018747.g002
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bial activity, CAMPs must bind to the bacterial surface, whether
they act by the inhibition of biosynthetic processes on the bacterial
surface, pore formation in the cytoplasmic membrane, or yet other
mechanisms. The bacterial surface is negatively charged owing to
the production of anionic polymers. Moreover, the outer and
inner leaflets of the bacterial cytoplasmic membrane are also
negatively charged. In Gram-positive bacteria, resistance to
CAMPs is mainly due to an increase of the positive surface
charge through increase in D-alanylation of the LTAs or
incorporation of L-lysine into membrane phosphatidylglycerol,
more rarely to specific proteolytic degradation [35]. PilB from
GBS strains NEM316 and NCTC10/84 display 84.5% of
sequence identity but the pilin subunit from NEM316 is positively
charged (+2; pKi 8.44) at neutral pH whereas that from
NCTC10/84 is slightly electronegative (22; pKi 6.57). These
observations, combined with the fact that GBS pili are not evenly
distributed along the bacterial surface, strongly argue against their
involvement in CAMP resistance by electrostatic repulsion and it is
worth noting that neither proteins contain any known proteolytic
Figure 3. Bacterial survival in cultured and primary murine macrophages. A- Immortalized RAW264.7 were cultured in vitro and exposed to
S. agalactiae NEM316 (WT), the non-piliated mutant (DpilB), and the sodA mutant (NEM1640) at an m.o.i. of 10 bacteria per cell in 24-wells plate. Error
bars represent the standard deviation of three independent experiments done in duplicate for each strain studied. B- Survival of S. agalactiae and L.
lactis strains in thioglycolate-elicitated primary murine peritoneal macrophages. Bacteria in exponential phase (OD600 of about 0.6) were added to
macrophages (m.o.i. of 10) for 30 min and then survival was measured after 2 h30 at 37uC. Error bars represent the standard deviation of a
representative experiment done in triplicate for each strain studied.
doi:10.1371/journal.pone.0018747.g003
Table 1. Minimal Inhibitory Concentrations (MIC90) of various
antimicrobial peptides towards GBS strain NEM316 (WT) and
its derivatives and L. lactis NZ9000 expressing or not the pilus
backbone subunit encoding gene pilB from the multicopy
vector pOri23.
S. agalactiae L. lactis
WT DpilB DdltA vec vecVpilB
AMP-1D 8 8 4 4 4
LL-37 .64 .64 16 16 16
Colistin .256 .256 16 .256 .256
Polymyxin B 128 128 8 .256 .256
Values are expressed in mg/ml.
doi:10.1371/journal.pone.0018747.t001
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modulate the susceptibility of the piliated original host nor that of
L. lactis towards 5 CAMPs including mCRAMP, whereas the
NEM316 DdltA mutant displayed increased susceptibility towards
all tested molecules.
We also demonstrated that NEM316 PilB is dispensable for
entry and survival within two different mouse-derived macro-
phage-like cell lines, RAW 264.7 (Fig. 3A) and MH-S of alveolar
origin (data not shown), in non-opsonic conditions. Macro-
phages respond to infection or injury by changing from a
« resting » cellular phenotype to an « activated » state defined
by the expression of various cytotoxic effector molecules.
Regulation of the transition from a resting to an activated state
is effected by cytokines and/or pathogenic signals. Thioglycolate
is often used to induce peritonitis in mice to recover primary
peritoneal macrophages. We thus tested survival of wild-type
GBS strain NEM316 and its isogenic DpilB mutant in this
cellular model mimicking in vivo situation and, again, did not
found any significant differences between WT and mutant
strains (Fig. 3). Heterologous expression of pilB from NEM316
in L. lactis did not confer any significant advantage for survival
in primary activated macrophages, as compared to the control
strain (Fig. 3). In conclusion, our results do not substantiate the
proposal that PilB is a major player in resistance to innate
immune host defenses, i.e. resistance to macrophage killing and
to antimicrobial peptides. However, we cannot exclude that
phenotypic differences are not duet os e q u e n c ev a r i a t i o n si nt h e
PilB proteins.
As natural GBS infections primarily occur in the neonatal
context, we compared the virulence of NEM316 WT and DpilB
strains in newborn BALB/c mice and found that the DpilB was
significantly less virulent than the wild-type NEM316 strain (Fig.
1CD). Thus, NEM316 PilB appears to contribute to virulence in
neonate but not in adult mice. In this work, it is worth
mentioning that newborn and adult mice were infected
subcutaneously and intravenously, respectively. However, we
consider unlikely that the observed difference in virulence reflects
the use of different modes of injection as, in our experience, adult
mice are highly sensitive to a GBS challenge administered i.v.
Indeed, we have infected subcutaneously two- and three- months
old adult mice (groups of 12 mice) with high doses of GBS
NEM316, ranging from 2.5610
8 to 10
9 cfu, and no mortality was
observed (data not shown).
Besides having an immature immune system, newborn are also
more permissive to infections than adult mice due to increased
bacterial translocation through the epithelia of their major organs,
such as intestine, lung, kidney, liver, and brain [36,37]. The GBS
PI-2a pilus operon was reported to promote biofilm formation,
adherence to human epithelial cells and transepithelial migration,
and adhesion and invasion of brain microvascular endothelial
cells. These phenotypic traits may therefore strongly impact GBS
virulence in neonate mice but not in adult mice, as observed in this
study. Our results also illustrate the fact that the definition of a
virulence factor primarily depends on the animal model used.
Hence, GBS pilus can be considered as a virulence factor in the
neonatal context.
Materials and Methods
Ethics statement
All of the animal experiments described in the present study were
conducted at the Metchnikoff Department of the University of
Messina according to the European Union guidelines for the
handling of laboratory animals (http://ec.europa.eu/environment/
chemicals/lab_animals/home_en.html) and were approved by the
relevant national authority (Istituto Superiore di Sanita ` of Italy).
Bacterial strains, media, and growth conditions
Streptococcus agalactiae NEM316 was responsible for a fatal
septicaemia and belongs to the capsular serotype III. The
complete genome sequence of this strain has been determined
[38]. S. agalactiae were grown in Todd-Hewitt (TH) medium
(Difco-BD). Lactococcus lactis strain NZ9000 [39] was grown in M17
medium supplemented with 1% glucose (GM17). For antibiotic
selection in L. lactis,5mg/ml erythromycin was added to GM17.
Heterologous expression of pilB in L. lactis strain was realized as
follows: The full-lengh pilB gene was amplified from genomic
DNA of strain NEM316 and subcloned in the lactococcal vector
pIL253::P23 [40], a high copy number erythromycin resistance
plasmid expressing the cloned gene from the strong constitutive
promoter P23 [41]. The primers used for pilB amplification were:
1477a (59-ATG GGC CCA TGA AAA AAA TCA ACA AAT
GTC TTA CAG T – 39) and 1477b (59 - ATA CTG CAG CCT
AAA TAA TGG CTC TTG CTT ATG – 39). The 2.1-kb PCR
product was then cut by ApaI and PstI (New England Biolabs),
purified, and cloned into pIL253::P23 cut with the same enzymes
resulting in pIL253::P23Vgbs1477 (pVE5616). This ligation
mixture was transformed to electrocompetent L. lactis IL1403.
After verification by DNA sequencing, pVE5616 was transferred
into L. lactis NZ9000.
General DNA techniques
Standard recombinant techniques were used for nucleic acid
cloning and restriction analysis [42]. Plasmid DNA from E. coli was
prepared by rapid alkaline lysis using the Nucleospin Plasmid kit
(Macherey-Nagel). Genomic DNA from S. agalactiae was prepared
using the DNeasy Blood and Tissue kit (Qiagen). PCR was carried
out with the High-Fidelity Phusion DNA polymerase as recom-
mended by the manufacturer (Finnzymes).
Immunoblotting
Cell wall protein extracts were prepared by harvesting 50 ml of
bacteria in early stationary phase (0D600=1). The bacterial pellet
was washed once in Tris-HCl buffer (50 mM, pH 7.3) and once in
the mutanolysin digestion buffer (Tris-HCl 50 mM pH 7.3
supplemented with 20% sucrose and a complete protease inhibitor
cocktail (Roche)). Mutanolysin (Sigma) dissolved to 5,000 U ml
21
in potassium phosphate buffer (pH 6.2) was then added to the
bacterial suspension to give a final concentration of 100 U ml
21
and samples were rotated for 2 h at 37uC. After centrifuging at
13,000 g for 15 min at 4uC, supernatants corresponding to the cell
wall extracts were analyzed on SDS-PAGE or kept frozen at
220uC. For western blotting, proteins were boiled in Laemmli
Figure 4. Effect of the murine cathelicidin mCRAMP on bacterial growth. Prewarmed TH broth buffered with HEPES (100 mM) and
containing or not mCRAMP was inoculated with overnight NEM316 (A), NEM316DpilB (B), and NEM316DdltA (C) to give approximately 10
7 cfu/ml. The
inoculated broth was distributed (150 ml) in 96 wells plate incubated at 37uC with constant shaking in a plate reader and the OD600 nm was recorded
every 20 minutes for 12 hours. Blank values (TH-HEPES) were subtracted from experimental values to eliminate background readings. m TH-HEPES
medium without peptide (sterile water was added instead); % and TH-Hepes medium containing 100 and 200 mg/ml of mCRAMP respectively.
These results are representative of three independent experiments.
doi:10.1371/journal.pone.0018747.g004
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4–12% SDS-PAGE gels (BioRad) and transferred to nitrocellulose
membrane (Hybond-C, Amersham). PilB was detected using
polyclonal antibodies and horseradish peroxydase (HRP)-coupled
anti-rabbit secondary antibodies (Zymed) and the Western pico
chemiluminescence kit (Thermo scientific).
Adult mouse infection model
Two groups of male CD-1 mice (6- weeks old) were injected
intravenously (i.v.) via the tail vein with the indicated amounts of
early logarithmic-phase of GBS or L. lactis strains. Mice were
monitored daily for survival. Bacteremia was assessed at 24 h by
blood collection and enumeration of CFUs on TH or M17 agar
plates.
Neonatal mouse model of GBS sepsis
Neonatal BALB/c mice were used for virulence studies.
Randomized groups of 7 to 10 mice pups were inoculated
subcutaneously with a dilution of mild-log-phase strain NEM316
or DpilB (0.03 ml of each strain in 0.9% NaCl). Under these
condition (from 17 to 60 CFU/mouse), GBS are contained at the
inoculation site or spread systematically, depending on the
bacterial intrinsic virulence factor and the ability of the host
immune system to prevent bacterial grow. Mice were observed
daily for up 8 days post-infection. In this model, deaths are rarely
observed after Day 5.
Assay for GBS intracellular survival in macrophages
Cells were infected at a multiplicity of infection (m.o.i.) of 10
bacteria per cell for 1 h at 37uC in 10% of CO2. The monolayers
were then washed four times with PBS and fresh medium
containing gentamicin (100 mg/ml) was added to kill extracellular
bacteria (time zero of the assay). To quantify intracellular GBS at
different times of post-infection, the supernatants were removed
and the cells were disrupted by the addition of 1 ml sterile
deionized ice-cold water and repeated pipetting. Serial dilutions of
the lysate were plated on TH agar for counting of viable bacteria.
Survival index was calculated as follows: (CFU on plate count/
CFU in original inoculum)6100. Assays were performed in
duplicate and were repeated at least three times.
Determination of the Minimal Inhibitory Concentration
(MIC)
The MICs (mg/ml) of S. agalactiae towards antimicrobial peptides
(AMP-1D, LL-37, colistin, and polymyxin B) were performed by a
dilution method in 96 wells polypropylene microplates (Costar,
Cambridge, MA) containing Todd-Hewitt (TH) broth buffered
with 100 mM HEPES using two biological replicates in duplicate.
Polymyxin B and colistin were purchased from Sigma whereas LL-
37 and AMP-1D were synthesized in the Department of Biological
Chemistry (Rehovot, Israel). Bacteria (approx. 10
5 CFU) were
added to wells containing increasing concentrations of the
antimicrobial peptides. Plates were incubated overnight at 37uC
and were then read at OD600 nm with a microplate reader BioTek
Synergy for bacterial growth. The MIC90 was considered and
expressed as the lowest peptide concentration inhibiting growth of
90% of the bacterial cells. The same experimental procedure was
used for L. lactis except that bacteria were grown at 30uC in M17
broth supplemented with glucose (1%) and erythromycin (5 mg/
ml).
Growth curves in the presence of mCRAMP
Overnight cultures of GBS in TH broth buffered with HEPES
(100 mM) were diluted in fresh media to give approximately
10
7 cfu/ml and 150 ml were distributed in 96 wells plate without
(control wells) or with mCRAMP at selected concentrations (test
wells). The microplate was incubated at 37uC with constant
shaking in the BioTek Synergy plate reader and the OD600 nm was
recorded every 20 min for 12 h. The same experimental
procedure was used for L. lactis except that bacteria were grown
at 30uC in M17 broth supplemented with glucose (1%) and
erythromycin (5 mg/ml). mCRAMP was purchased from TEBU.
Supporting Information
Figure S1 Effect of the murine cathelicidin mCRAMP on
bacterial growth. Overnight culture of the control strain L. lactis
NZ9000/vec (A) or the L. lactis NZ9000/vecVpilB strain
expressing the GBS PilB protein (B) were diluted in M17 broth
supplemented with glucose (1%) and erythromycin (5 mg/ml) to
give approximately 10
6 cfu/ml. The inoculated broths were
distributed (150 ml) in 96 wells plate incubated at 30uC with
constant shaking in a plate reader and the OD600 nm was recorded
every 20 minutes for 12 hours. Blank values (M17-glucose-
erythromycin) were subtracted from experimental values to
eliminate background readings. m, M17-glucose-erythromycin
medium without peptide (sterile water was added instead); &,
presence of the mCRAMP drug at 5 (light blue), 10 (violet), 20
(green), and 40 (red) mg/ml, respectively. These results are
representative of three independent experiments.
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